Alembic Pharma
₹789.45-3.20 (-0.40%)as of 2026-10-16
- Market Cap
- ₹15,549Cr.
- P/E Ratio
- 20.8
- P/B Ratio
- 2.73
- EPS (TTM)
- ₹37.95
- Day Range
- ₹771 – ₹793
- Div Yield
- 1.47%
- ROCE
- 12.6%
- ROE
- 13.4%
52W Low: ₹63652W High: ₹998
Themes:💊 Pharma & CDMO
Descriptive screens built from published data — not investment advice.
At a glance
- Sales have grown 9.0% a year over three years.
- Debt is 0.25× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
Alembic_Pharma — Price
Interval
Style
Failed: 503
Evenstocks Score
Middle third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 20.8P/E: 20.8 | P/B: 2.73Growth
ModestSales CAGR — 3Y: 9% · 1Y: 14%Profitability
ModerateROCE: 12.6% | ROE: 13.4%Key Metrics
Valuation
PEG Ratio 0.74
Price / Sales 2.00x
Price / FCF 53.6x
Book Value ₹289
Margins & returns
Operating Margin 15%
Net Margin 8.9%
Return on Assets 7.9%